12 Health Care Stocks Moving In Friday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Celyad Oncology CYAD shares rose 22.75% to $4.37 during Friday's pre-market session. The company's market cap stands at $70.3 million.
  • Biolase BIOL shares increased by 16.73% to $0.48. The market value of their outstanding shares is at $73.1 million.
  • AirSculpt Technologies AIRS shares increased by 9.94% to $11.5. The company's market cap stands at $639.8 million. As per the press release, Q3 earnings came out today.
  • Syros Pharmaceuticals SYRS shares moved upwards by 8.37% to $4.14. The company's market cap stands at $256.4 million.
  • Tivic Health Systems TIVC stock moved upwards by 8.28% to $4.38. The market value of their outstanding shares is at $42.5 million.
  • Histogen HSTO shares increased by 7.97% to $0.47. The market value of their outstanding shares is at $19.6 million.
  •  

Losers

  • Esperion Therapeutics ESPR shares declined by 31.0% to $6.19 during Friday's pre-market session. The market value of their outstanding shares is at $179.9 million.
  • Valneva VALN shares declined by 17.56% to $51.84. The market value of their outstanding shares is at $2.7 billion.
  • 2seventy bio TSVT stock fell 6.23% to $26.66. The company's market cap stands at $620.8 million.
  • Chemomab Therapeutics CMMB shares declined by 5.93% to $8.1. The market value of their outstanding shares is at $92.3 million.
  • TherapeuticsMD TXMD shares decreased by 5.83% to $0.47. The market value of their outstanding shares is at $200.0 million.
  • Cumberland CPIX stock decreased by 4.98% to $4.01. The company's market cap stands at $59.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Pre-Market OutlookMarketsMoversBZI-TFMTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...